Category

NASDAQ

1 Reason Why Apple Stock Is a Screaming Buy Right Now, and It Is Not the Vision Pro NASDAQ

1 Reason Why Apple Stock Is a Screaming Buy Right Now, and It Is Not the Vision Pro

Apple (NASDAQ: AAPL) announced its long-rumored mixed-reality headset at the company's Worldwide Developers Conference on June 5, and Wall Street's reaction to the device hasn't quite been enthusiastic. Shares of Apple haven't moved much since the formal announcement of the Vision Pro headset. That's not surprising given that Apple has…
bubmag
June 15, 2023
Hexo Corp.’s Shareholders Approve Acquisition by Way of Arrangement With Tilray Brands, Inc. NASDAQ

Hexo Corp.’s Shareholders Approve Acquisition by Way of Arrangement With Tilray Brands, Inc.

Author of the article: Published Jun 14, 2023  •  6 minute read GATINEAU, Québec — HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”) announced today that at the special meeting of its common shareholders held earlier today, its common shareholders approved the previously announced arrangement agreement, as amended,…
bubmag
June 14, 2023
Forza X1 Receives Order from OneWater Marine Indicating its Intention to Initially Purchase 100 Units of the Company’s 22-foot Electric Boats NASDAQ

Forza X1 Receives Order from OneWater Marine Indicating its Intention to Initially Purchase 100 Units of the Company’s 22-foot Electric Boats

FORT PIERCE, FL / ACCESSWIRE / June 9, 2023 / Forza X1, Inc. (Nasdaq:FRZA) ("Forza," the "Company"), a developer of electric sport boats aimed at promoting sustainable recreational boating, announced today that it received an initial purchase order from OneWater Marine, Inc. (Nasdaq:ONEW) indicating its intention to purchase 100 units…
bubmag
June 9, 2023
Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer’s Disease in South Korea NASDAQ

Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer’s Disease in South Korea

Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer's Disease in South Korea TOKYO and CAMBRIDGE, Mass., Jun 08, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai has submitted a marketing authorization application for lecanemab (brand name in…
bubmag
June 8, 2023